This federal contract award is a delivery order (SPE2DB22D1106|SPE2DB25FDSC5) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $68,618.48 firm fixed-price contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a period of performance through December 30, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, both of which cover a range of pharmaceutical and medical supply products to support federal healthcare programs.
Generated 3/28/25, 9:52 AM